NICARDIPINE |
NICARDIPINO |
(R,S)-NICARDIPINE |
CARDENE® |
NICARDIPINUM |
LOX725 |
pubchem.compound:4474 |
chemidplus:55985-32-5 |
drugbank:00622 |
chembl:CHEMBL1484 |
rxcui:7396 |
FDA Approval | 1988 |
Drug Class | small molecule |
Drug Indications | Antihypertensive Agents |
Drug Indications | Anti-Arrhythmia Agents |
Drug Class | anti-arrhythmia agents |
Year of Approval | 1988 |
Drug Class | antihypertensive agents |
Drug Categories | calcium channel blockers (dihydropyridine) |
Drug Groups | investigational |
Drug Categories | adrenergic alpha-1 receptor antagonists |
Drug Categories | adrenergic alpha-antagonists |
Drug Categories | adrenergic antagonists |
Drug Categories | agents causing hyperkalemia |
Drug Categories | agents producing tachycardia |
Drug Categories | antiarrhythmic agents |
Drug Categories | anticholinergic agents |
Drug Categories | antihypertensive agents indicated for hypertension |
Drug Categories | bradycardia-causing agents |
Drug Categories | bsep/abcb11 substrates |
Drug Categories | calcium-regulating hormones and agents |
Drug Categories | cytochrome p-450 cyp2b6 inducers (strength unknown) |
Drug Categories | cytochrome p-450 cyp2c19 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp2c8 inhibitors (moderate) |
Drug Categories | cytochrome p-450 cyp2c9 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors (moderate) |
Drug Categories | cytochrome p-450 cyp3a5 inhibitors |
Drug Categories | cytochrome p-450 cyp3a5 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 enzyme inducers |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | muscarinic antagonists |
Drug Categories | oatp1b1/slco1b1 inhibitors |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | p-glycoprotein substrates |
Drug Categories | potential qtc-prolonging agents |
Drug Categories | qtc prolonging agents |
Drug Categories | vasodilating agents |
inhibitor (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
NICARDIPINE | DrugBank Drug Name |
55985-32-5 | CAS Number |
Cardene | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
NICARDIPINE | Primary Drug Name |
Drug Class | antihypertensive agents |
Year of Approval | 1988 |
Drug Class | anti-arrhythmia agents |
Drug Indications | Anti-Arrhythmia Agents |
Drug Indications | Antihypertensive Agents |
Drug Class | small molecule |
C29840 | NCI drug code |
CHEMBL1484 | ChEMBL Drug ID |
D0T0KA | TTD Drug ID |
NICARDIPINE | GuideToPharmacology Ligand Name |